Prevent Timeline Errors in a GLP-1 Cohort

The research question

A cohort study needs a clear starting point shared by the treatment groups. Eligibility, exposure assignment, and follow-up should align according to the research question. When treatment is defined using future information, the timeline can introduce bias. Drawing the sequence of events often reveals issues hidden in a statistical table.

How to interpret the evidence

Investigators should state when treatment begins, how switching is handled, when outcomes become eligible, and how follow-up ends. A grace period for starting therapy requires an appropriate analysis plan. Sensitivity analyses can examine alternative exposure definitions. Thoughtful timing makes the comparison more interpretable and supports a transparent discussion of its limitations.

Protocol planning principles support explicit timelines and analysis definitions. This article presents an original educational framework for inspecting observational study timing.

Exposure may also change during follow-up. Participants can discontinue, switch, restart, or change dose. The analysis should explain which question its exposure definition answers and how these changes are handled. A fixed initial assignment and an analysis tracking ongoing treatment describe different comparisons. Explicit wording helps readers understand the interpretation of each approach.

Practice the appraisal

Original timeline exercise: imagine treatment users are classified only after completing several prescriptions, while comparison participants enter at their first clinic visit. Draw both timelines and ask what must happen before a participant qualifies for the treated group. Any required survival or continued observation deserves explicit design consideration. Align eligibility, exposure assignment, and start of follow-up in a revised sketch. This is a hypothetical methodological example, not a description of a named GLP-1 study. A real appraisal should verify the published timeline and analytic handling of treatment changes.

Apply the lesson

For a design review, draw a participant timeline for each comparison group. Mark the moment at which treatment status becomes known and the moment at which outcome follow-up starts. Inspect whether either group requires survival or continued participation to qualify. This simple exercise can guide more appropriate eligibility and analysis decisions before a large dataset creates a misleading appearance of precision.